Higher body mass index and positive smoking status predict poorer phototherapy response
TUESDAY, Oct. 26, 2021 (HealthDay News) — The Psoriasis Area and Severity Index (PASI) clearance trajectory over the first few weeks of type B ultraviolet (UVB) phototherapy may predict psoriasis clearance, according to a study published in the November issue of the Journal of the European Academy of Dermatology and Venereology.
Nicola Watson, from the Newcastle Hospitals NHS Foundation Trust in the United Kingdom, and colleagues investigated the associations of selected serum biomarkers and the trajectory of response with outcomes of UVB phototherapy. The analysis included 100 patients with psoriasis routinely prescribed narrowband UVB with 18 months of follow-up data.
